These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 19363668)

  • 1. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus.
    Hammond SA; Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Sep; 262(2):416-30. PubMed ID: 10502520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
    Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
    Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement.
    Raabe ML; Issel CJ; Cook SJ; Cook RF; Woodson B; Montelaro RC
    Virology; 1998 May; 245(1):151-62. PubMed ID: 9614876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein.
    Wang SZ; Rushlow KE; Issel CJ; Cook RF; Cook SJ; Raabe ML; Chong YH; Costa L; Montelaro RC
    Virology; 1994 Feb; 199(1):247-51. PubMed ID: 8116252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.
    Lin YZ; Shen RX; Zhu ZY; Deng XL; Cao XZ; Wang XF; Ma J; Jiang CG; Zhao LP; Lv XL; Shao YM; Zhou JH
    Antiviral Res; 2011 Nov; 92(2):292-304. PubMed ID: 21893100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.
    Ma J; Shi N; Jiang CG; Lin YZ; Wang XF; Wang S; Lv XL; Zhao LP; Shao YM; Kong XG; Zhou JH; Shen RX
    Virology; 2011 Feb; 410(1):96-106. PubMed ID: 21094511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.
    Craigo JK; Sturgeon TJ; Cook SJ; Issel CJ; Leroux C; Montelaro RC
    Virology; 2006 Jan; 344(2):340-53. PubMed ID: 16226288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of the correlation between the plasma viral load and protective immunity induced by the equine infectious anemia attenuated vaccine and its parental virulent strain].
    Cao XZ; Lin YZ; Li L; Jiang CG; Zhao LP; Lv XL; Zhou JH
    Bing Du Xue Bao; 2010 Mar; 26(2):128-33. PubMed ID: 20480642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope determinants of equine lentiviral vaccine protection.
    Craigo JK; Ezzelarab C; Cook SJ; Chong L; Horohov D; Issel CJ; Montelaro RC
    PLoS One; 2013; 8(6):e66093. PubMed ID: 23785473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study on an attenuated Chinese EIAV vaccine inducing broadly neutralizing antibodies.
    Meng Q; Lin Y; Ma J; Ma Y; Zhao L; Li S; Liang H; Zhou J; Shen R; Zhang X; Shao Y
    Arch Virol; 2011 Aug; 156(8):1455-62. PubMed ID: 21499906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse mutation of the virulence-associated S2 gene does not cause an attenuated equine infectious anemia virus strain to revert to pathogenicity.
    Gao X; Jiang CG; Wang XF; Lin YZ; Ma J; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
    Virology; 2013 Sep; 443(2):321-8. PubMed ID: 23763769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
    Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
    Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
    Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
    Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and immunogenicity of equine infectious anemia virus membrane protein GP90].
    Dai CB; Xiao Y; Lu H; Shen RX; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):73-6. PubMed ID: 12870025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
    Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
    Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.